We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Stratifies Patient Populations for Depression

By LabMedica International staff writers
Posted on 04 May 2009
A neurodiagnostic company has developed a blood test for depression or major depressive disorder (MDD). More...
Physicians believe it will improve the acceptance of the diagnosis and yield a higher level of treatment.

The test will be used by psychiatrists and primary care physicians to diagnose and monitor treatment of patients with depression. The tests are based on panels of biomarkers that predictably shift when a patient is depressed. Products are based on a human biomarker library with hyper-mapping technology.

A biologic test based upon the physiologic changes caused by depression could guide the earlier diagnosis and treatment management of the over 20 million adults in the United States suffering from this disease.

Ridge Diagnostics, Inc. (San Diego, CA, USA, and Research Triangle Park, NC, USA) has been awarded a phase II, National Science Foundation, Small Business Innovation Research (SBIR) Program grant. The grant will be used to further the clinical development and commercialization of its blood test for depression, the first blood test for any neuropsychiatric disorder.

Ridge Diagnostics testing services are provided through a clinical laboratory improvement amendments- (CLIA)-certified laboratory in North Carolina, then through diagnostic test kits sold worldwide. The company intends to develop a comprehensive neuropsychiatric disease franchise.

Related Links:

Ridge Diagnostics, Inc




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.